Anthropic, an AI lab, is preparing for a significant IPO, aiming for a valuation of $1.5 trillion, making it the first major AI frontier lab to enter public markets. As a public benefit corporation, Anthropic must navigate the dual responsibilities of generating profit while fulfilling its mission to develop AI for the long-term benefit of humanity.
This PBC status complicates traditional corporate governance, as the company is required to balance shareholder interests with its public benefit goals. Legal experts have raised concerns about the ambiguity of the term 'balance' in PBC law, suggesting that it may be challenging for directors to prioritize between profit and public purpose.
Anthropic's commitment to AI safety, including restricting access to potentially dangerous models, may also affect its revenue growth. Analysts emphasize that investors should carefully consider the implications of the PBC structure, as it limits shareholder control and could introduce uncertainties in investment outcomes.
The company has multiple share classes, with co-founders holding significant voting power, which further complicates governance. While Anthropic could potentially change its PBC status in the future, the evolving landscape of the AI sector suggests that investors should remain vigilant about ongoing developments and regulatory changes